Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis | Synapse

May 19, 2016

Ver artículo completo

Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis

SMShinnosuke MuramatsuKonan Kosei Hospital RKRyoji KuboNagoya City University ENEmi NishidaNagoya City University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Serum IL-6 level may be a useful biomarker for assessing disease activity in patients with psoriasis and for predicting responsiveness of joint symptoms to biologic treatment.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Muramatsu et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd691330fba8aacf40c5e1 https://doi.org/https://doi.org/10.3109/14397595.2016.1174328

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides1988 · 856 citations
2Cytokine profiles during infliximab monotherapy in psoriatic arthritis2005 · 95 citations
3Serum Levels of TNF‐<i>α</i>, IFN‐<i>γ</i>, IL‐6, IL‐8,IL‐12, IL‐17, and IL‐18 in Patients With Active Psoriasis andCorrelation With Disease Severity2005 · 795 citations
4Palladium Nanoparticles Induce Disturbances in Cell Cycle Entry and Progression of Peripheral Blood Mononuclear Cells: Paramount Role of Ions2014 · 265 citations
5The Path Forward to Biomarker Discovery in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting2012 · 4 citations